SKKU-Yuhan-Imnewrun, Signed Cooperation Agreement on <Uni-Industry Convergence Brain Disease R&BD Ecosystem Establishment Project>

[Image 1] Photo of inauguration – (from left) Ceo of Yuhan, Jung-Hee Lee, President of SKKU, Dong-Ryeol Shin, Ceo of Umnewrun, Han-Ju Kim 

SKKU announced on September 23 that it has signed a three-way cooperation agreement with Yuhan and Imnewrun on <Uni-Industry Convergence Brain Disease R&BD Ecosystem Establishment Project>. They plan to build sustainable uni-industry convergence brain disease R&BD ecosystem starting by building the CNS research center in the natural science campus of SKKU.

SKKU-Yuhan-Imnewrun will establish a CNS research center and a new department in the field of basic brain science, and cooperate on joint-research and new drug development through this agreement.

The three-way agreement is significant because it realize an innovative platform of one-stop univ-industry collaboration to create a differentiated brain disease R&BD ecosystem that is converged by universities, bio-venture, and pharmaceutical companies for the first time in Korea.

Upon this agreement, they will build the CNS research center that has cutting-edge education and research facilities inside the Natural Science Campus of SKKU. The construction will begin in 2021 and aims to complete at the end of 2023. At the inauguration ceremony, they also had a ceremony for building the new CNS research center.

[Image 2] Photo of commemorating new construction

With this cooperation, SKKU plans to build the CNS research center, have cutting edge research facilities, and establish a new department to cultivate global leaders. Yuhan will focus and strengthen its R&D capabilities in developing new drugs for internal brain diseases and to continuously expand its CNS pipeline with promising business feasibility through investment and joint development. Imnewrun also plans to speed up the development of technologies and new drugs in the field of brain diseases and genetic disease based on their superior brain science research infrastructure.